Écrit par GlobalData | 01 Août 2012

LONDON, UK (GlobalData), 26 July 2012 - IntelligentMDx received EU approval of their new diagnostic test, IMDx HSV-1/2, which detects the presence of HSV nucleic acids and differentiates between Herpes simplex virus 1 and 2 (HSV-1 and HSV-2). The IMDx HSV-1/2 is designed to complement the use of the Abbott m2000 RealTime system, manufactured by Abbott Molecular, a subsidiary of Abbott...

Écrit par Pluristem | 23 Juillet 2012

HAIFA, ISRAEL, July 18, 2012 -- Pluristem Therapeutics, Inc. (NASDAQ:PSTI; TASE: PLTR), today announced that in anticipation of initiating a Phase II study using PLX-PAD cells for the treatment of Intermittent Claudication (IC), the company has recently entered into a collaborative agreement with CPC Clinical Research (CPC) for services related to enrolling and sustaining clinical sites...

Écrit par Globaldata | 19 Juillet 2012

LONDON, UK (GlobalData), 18 July 2012 - GlaxoSmithKline (GSK), the British pharmaceutical giant, acquired Human Genome Sciences (HGS) on Monday, July 16, 2012 for $14.25/share. On an equity basis this deal was worth about $3.6 billion; however, the final deal size was approximately $3 billion net of cash and debt. GSK paid a premium of 99% from when it offered its initial private...

Écrit par GBI | 16 Juillet 2012

NEW YORK (GBI Research), 13 July 2012 - Biobetters, drugs that have been improved since their initial incarnations, are demonstrating fantastic growth and leaving their originators well behind, states new research by pharmaceutical business specialists GBI Research.

The new report* explains how the more advanced drugs are far outstripping their biologic predecessors in terms of sales and...